When Milenko Cicmil, PhD, first heard about the technology underlying Tasca Therapeutics, a newly-minted small molecular inhibitor company, he was intrigued. The privately-held company ...

The company's new 427,000-square-foot facility will feature advanced automation and expanded service capabilities.

BOSTON--(BUSINESS WIRE)--Tasca Therapeutics Corp. (“Tasca”), a biotechnology company leveraging a unique drug discovery platform that identifies and maps novel lipid-binding pockets on proteins to ...

We create communities of learning that amplify Pulitzer Center journalism through education and outreach programs, connecting teachers, students, artists, influencers, and decision makers with stories ...